Literature DB >> 9278769

Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures.

S Masunaga1, K Ono, M Suzuki, Y Kinashi, M Takagaki, M Akaboshi.   

Abstract

We investigated oxygenation of quiescent (Q) tumour cells in vivo by mild heat treatment. C3H/He mice bearing SCC VII tumours received BrdU continuously for 5 days via implanted mini-osmotic pumps, to label all proliferating (P) cells. The tumours were then irradiated after treatment, and were excised, minced and trypsinized. The tumour cell suspension thus obtained were incubated with cytochalasin-B (a cytokinesis blocker), and the micronucleus (MN) frequency in cells without BrdU labelling was determined using immunofluorescence staining for BrdU. This MN frequency was then used to calculate the surviving fraction of unlabelled cells from the regression line for the relationship between the MN frequency and the surviving fraction of total (P + Q) tumour cells. Thus, a cell survival curve could be determined for the cells not labelled with BrdU, which can be regarded as the Q cells in a tumour for all practical purposes. The MN frequency in total tumour cell population was determined from the irradiated tumours that were not pretreated with BrdU. Assays performed immediately after irradiation of both normally aerated and hypoxic tumours showed that Q cells contained higher hypoxic fractions than the total tumour cell population. Mild heat treatment (40.0 degrees C, 60 min) before irradiation decreased the hypoxic fraction, even when is was combined with nicotinamide administration. In contrast, mild heating did not decrease the hypoxic fraction when the mice were placed in a circulating carbogen (95% O2/5% CO2) chamber. Therefore, mild heat treatment was thought to preferentially oxygenate the chronically hypoxic fraction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278769     DOI: 10.3109/02656739709046541

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  10 in total

1.  Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.

Authors:  S Masunaga; Y Matsumoto; G Kashino; R Hirayama; Y Liu; H Tanaka; Y Sakurai; M Suzuki; Y Kinashi; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population.

Authors:  Shin-ichiro Masunaga; Ryoichi Hirayama; Akiko Uzawa; Genro Kashino; Takushi Takata; Hiroki Tanaka; Minoru Suzuki; Yuko Kinashi; Yong Liu; Sachiko Koike; Koichi Ando; Koji Ono
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

3.  Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

Authors:  S Masunaga; Y Sakurai; H Tanaka; M Suzuki; Y Liu; N Kondo; A Maruhashi; Y Kinashi; K Ono
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

4.  Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.

Authors:  S Masunaga; Y Liu; H Tanaka; Y Sakurai; M Suzuki; N Kondo; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

5.  Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Yoshitaka Matsumoto; Ryoichi Hirayama; Genro Kashino; Hiroki Tanaka; Minoru Suzuki; Yuko Kinashi; Yong Liu; Koichi Ando; Koji Ono
Journal:  Clin Exp Metastasis       Date:  2009-05-23       Impact factor: 5.150

6.  Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Keizo Tano; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2013-03-06

7.  Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.

Authors:  S I Masunaga; K Ono; M Suzuki; Y Kinashi; M Takagaki; H Hori; S Kasai; H Nagasawa; Y Uto
Journal:  Jpn J Cancer Res       Date:  2000-05

8.  Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.

Authors:  Shin-Ichiro Masunaga; Yu Sanada; Takahiro Moriwaki; Keizo Tano; Yoshinori Sakurai; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Tsubasa Watanabe; Yosuke Nakagawa; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2014-08-25

9.  An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.

Authors:  Shin-Ichiro Masunaga; Yu Sanada; Keizo Tano; Yoshinori Sakurai; Hiroki Tanaka; Takushi Takata; Minoru Suzuki; Koji Ono
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

10.  Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Keizo Tano; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Tsubasa Watanabe; Yosuke Nakagawa; Akira Maruhashi; Koji Ono
Journal:  Exp Ther Med       Date:  2014-05-08       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.